- Research works
- 6 ▼ 8% vs 2013–17
- Citations
- 296 50.2 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 69% world 28%
Not ranked overall: TechnoVax (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does TechnoVax (United States) publish most on?
By volume in 2022–2025: Virus-based gene therapy research, CRISPR and Genetic Engineering, Viral Infectious Diseases and Gene Expression in Insects and Viral gastroenteritis research and epidemiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Virus-based gene therapy research Genetics 0 works
- 2 CRISPR and Genetic Engineering Molecular Biology 0 works
- 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 4 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 6 CAR-T cell therapy research Oncology 0 works
- 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 9 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 0 works
- 10 Cancer-related molecular mechanisms research Cancer Research 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has TechnoVax (United States)'s research output changed?
Output in 2018–2022 was 8% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Elmsford
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.